STRS Ohio’s Principia Biopharma Inc. Common Stock PRNB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
– Sell
-12,000
Closed -$717K – 2326
2020
Q2
$717K Sell
12,000
-500
-4% -$30.9K ﹤0.01% 1069
2020
Q1
$742K Sell
12,500
-1,100
-8% -$64.1K ﹤0.01% 859
2019
Q4
$745K Hold
13,600
– – ﹤0.01% 1129
2019
Q3
$384K Buy
+13,600
New +$499K ﹤0.01% 1424
2019
Q2
– Sell
-4,800
Closed -$163K – 2257
2019
Q1
$163K Buy
4,800
+3,300
+220% +$105K ﹤0.01% 1720
2018
Q4
$41K Buy
+1,500
New +$38.7K ﹤0.01% 1905

Other funds holding PRNB

STRS Ohio's PRNB Position: Q3 2020 in Review

STRS Ohio sold out of Principia Biopharma Inc. Common Stock (PRNB) in Q3 2020, closing a stake of 12,000 shares — an estimated $717K sold.

STRS Ohio first reported a position in PRNB in Q4 2018 and held it in 6 quarters. The position peaked at $745K in Q4 2019. 9 funds tracked by Wall St. Rank hold PRNB as of Q3 2020.

  • STRS Ohio reported no remaining Principia Biopharma Inc. Common Stock position as of Q3 2020 after selling out during the quarter.
  • STRS Ohio sold 12,000 Principia Biopharma Inc. Common Stock shares in Q3 2020, an estimated $717K.
  • STRS Ohio first reported a position in Principia Biopharma Inc. Common Stock in Q4 2018 and held it in 6 quarters.
  • STRS Ohio's Principia Biopharma Inc. Common Stock position peaked at $745K in Q4 2019.
  • 9 funds tracked by Wall St. Rank held Principia Biopharma Inc. Common Stock as of Q3 2020.

Based on STRS Ohio's 13F filing for Q3 2020, filed 14 Dec 2020.